Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

US: Bristol-Myers to Pay Fine

Agence France Presse
May 31st, 2007

Bristol-Myers Squibb has agreed to plead guilty and pay a $1 million criminal fine for lying to the government about a patent deal on its blood-thinning drug Plavix, officials said Wednesday.
The Justice Department said in a statement that the company’s actions had threatened to reduce competition for the drug, one of the best-selling prescription medications worldwide.

Government investigators said that a former senior Bristol-Myers executive had made “oral representations” to a Canadian generic drug maker, Apotex, that caused Apotex to conclude that Bristol-Myers would not introduce its own generic version of Plavix.

At the time, the two companies were locked in litigation over the validity of the patent for Plavix. Bristol-Myers, however, was subject to a consent decree that required it to submit any patent settlements for review with the Federal Trade Commission.

The government said that Bristol-Myers had also lied to the government about the arrangement. The government inquiry is still open.
The patent deal’s failure led to the ouster of Bristol-Myers’s chief executive, Peter R. Dolan, in September.






This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.